Indivior Pharmaceuticals, Inc. (INDV)
34.87
-0.43
(-1.22%)
USD |
NASDAQ |
Aug 28, 16:00
34.87
0.00 (0.00%)
After-Hours: 20:00
Indivior Pharmaceuticals Cash and Short Term Investments (Quarterly) : 222.00M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 222.00M |
| March 31, 2026 | 175.00M |
| December 31, 2025 | 195.00M |
| September 30, 2025 | 445.00M |
| June 30, 2025 | 510.00M |
| March 31, 2025 | 373.00M |
| December 31, 2024 | 320.00M |
| September 30, 2024 | 318.00M |
| June 30, 2024 | 379.00M |
| March 31, 2024 | 330.00M |
| December 31, 2023 | 410.00M |
| September 30, 2023 | 722.00M |
| June 30, 2023 | 689.00M |
| March 31, 2023 | 705.00M |
| December 31, 2022 | 893.00M |
| September 30, 2022 | 918.00M |
| June 30, 2022 | 934.00M |
| March 31, 2022 | 939.00M |
| December 31, 2021 | 1.102B |
| September 30, 2021 | 1.005B |
| June 30, 2021 | 1.00B |
| March 31, 2021 | 945.00M |
| December 31, 2020 | 858.00M |
| Date | Value |
|---|---|
| September 30, 2020 | 929.00M |
| June 30, 2020 | 908.00M |
| March 31, 2020 | 912.00M |
| December 31, 2019 | 1.060B |
| September 30, 2019 | 1.023B |
| June 30, 2019 | 988.00M |
| March 31, 2019 | 1.054B |
| December 31, 2018 | 924.00M |
| September 30, 2018 | 901.00M |
| June 30, 2018 | 951.00M |
| March 31, 2018 | 895.00M |
| December 31, 2017 | 863.00M |
| September 30, 2017 | 806.00M |
| June 30, 2017 | 792.00M |
| March 31, 2017 | 729.00M |
| December 31, 2016 | 692.00M |
| September 30, 2016 | 586.00M |
| June 30, 2016 | 577.00M |
| March 31, 2016 | 543.00M |
| December 31, 2015 | 467.00M |
| September 30, 2015 | 552.00M |
| June 30, 2015 | 523.00M |
| March 31, 2015 | 466.00M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | 372.07M |
| Liquidia Corp. | 284.18M |
| Corcept Therapeutics, Inc. | 308.20M |
| Prestige Consumer Healthcare, Inc. | 89.13M |
| Harrow, Inc. | 83.89M |